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This paper investigated the potential eﬀects of zerumbone pretreatment on an acute necrotizing pancreatitis rat model induced by
sodiumtaurocholate.ThepancreatitisinjurywasevaluatedbyserumAMY,sPLA2,andpancreaticpathologicalscore.Pancreatitis-
induced hepatic injury was measured by ALT, AST, and hepatic histopathology. The expression of I-κBα and NF-κBp r o t e i n
was evaluated by western blot and immunohistochemistry assay while ICAM-1 and IL-1β mRNA were examined by RT-PCR.
The results showed that AMY, sPLA2, ALT, and AST levels and histopathological assay of pancreatic and hepatic tissues were
signiﬁcantly reduced following administration of zerumbone. Applying zerumbone also has been shown to inhibit NF-κB
protein and downregulation of ICAM-1 and IL-1β mRNA. The present paper suggests that treatment of zerumbone on rat
attenuates the severity of acute necrotizing pancreatitis and pancreatitis-induced hepatic injury, via inhibiting NF-κB activation
and downregulating the expression of ICAM-1 and IL-1β.
1.Introduction
Acute necrotizing pancreatitis (ANP) is an acute abdomen-
characterized disease, and it is characterized by elevated pan-
creatic enzyme levels. Published data has indicated that ANP
is an inﬂammatory disease with a systemic inﬂammatory
response syndrome and a multiple organ dysfunction [1, 2],
and hepatic injury is a manifestation of systemic inﬂamma-
toryresponseduringANP[3].Hepaticmicrocirculatorydys-
function, tissue hypoxia, and inﬂammatory cytokines also
induce hepatic injury by resident macrophages during the
progress of pancreatitis [4–6]. Therefore, an eﬀective phar-
macological amelioration of hepatic injury could improve
the quality of life in ANP patients.
Zerumbone (2,6,9,9-tetramethylcycloundeca-2,6,10-tri-
en-1-one), as the main component of the essential oil of
Zingiber zerumbet, is a monocyclic sesquiterpene containing
a cross-conjugated dienone system [7]. It has been shown
to have antineoplasms and anti-inﬂammatory properties in
animal models. Some studies reported that zerumbone had
the ability to suppress the proliferation of cancer cells and
inhibittheinvasionoftumorinbreast,pancreas,colon,lung,
and skin [8–11]. The anti-inﬂammation eﬀect of zerumbone
was evaluated by the suppression of proinﬂammatory gene
and the antioxidant response of element-dependent detoxi-
ﬁcation pathway [12–17]. Moreover, Annamaria et al. indi-
cated that zerumbone exerted a beneﬁcial eﬀect on inﬂam-
matory parameters following experimental pancreatitis [18].
However, there is little available information on how zerum-
bone regulates pancreatitis-induced hepatic injury. This
work places emphasis on the eﬀect of zerumbone on hepatic
injury following ANP, suggesting that zerumbone could be a
good candidate to attenuate the severity of acute necrotizing
pancreatitis and pancreatitis-induced hepatic injury.
2.MaterialsandMethods
2.1. Animals and Reagents. Male SPF Wistar rats, weighing
200 to 250g, were obtained from the Center of Experimental2 Mediators of Inﬂammation
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Figure 1: (a) Levels of serum amylase (AMY), (c) alanine aminotransferase (ALT), and (d) glutamic oxalacetic transaminase (AST)
were measured by an automatic biochemistry analyzer with standard techniques (Olympus Optical Ltd., Japan); (b) serum secretory
phospholipase A2 (sPLA2) activity was measured by sPLA2 Assay Kit according to the manufacturer’s instructions. aP < 0.05 versus CON
group. bP < 0.05 versus TC group.
Animals of Hubei Academy of Medical Sciences, Wuhan,
China. The animals were kept at room temperature and 12h
light-dark cycles, and with free access to water. Rats in this
study were maintained in accordance with the principles of
the 1983 Declaration of Helsinki by the Ethics Committee of
Wuhan University. Zerumbone (purity > 99%) was obtained
from Kingherb’s company (Hainan, China). Sodium tau-
rocholate and dimethyl sulfoxide (DMSO) were purchased
f r o mS i g m aA l d r i c hC o m p a n y( S t .L o u i s ,M O ) .P r i m e r s
were designed and synthesized by Invitrogen Corporation
(Carlsbad, CA).
2.2. Induction of Acute Necrotizing Pancreatitis. Rats were
fasted overnight and given fresh tap water ad libitum. Anes-
thesia was administered by intraperitoneal injection of 10%
chloraldurat (3mL/kg). The pancreatic bile duct was cannu-
lated through the duodenum. Acute necrotiz- ing pancreati-
tis was induced by a standardized retrograde infusion of a
freshly prepared 5% sodium taurocholate solution (1mg/kg)
into the biliary-pancreatic duct. Isotonic saline solution
(20mL/kg)wasinjectedintothebacktocompensateforﬂuid
loss.
2.3. Experimental Design. The primary objective of a prelim-
inary study was to obtain the optimal dose of zerumbone for
preventing pancreatitis-induced hepatic injury. The second
study was a formal study, which was to explore the eﬀect
of zerumbone on hepatic injury following ANP. Zerumbone
was dissolved in vehicle (10% DMSO v/v) in this study.
In the preliminary study, rats were randomly divided
into sham-operated group, acute necrotizing pancreatitis
g r o u p ,a n dz e r u m b o n e - p r e t r e a t e ds u b g r o u p s( n = 8p e r
group) (Table 1). Zerumbone was injected via femoral vein
at various doses (5, 10, 20, and 40mg/kg) in zerumboneMediators of Inﬂammation 3
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Figure 2: Morphologic changes in pancreatic tissue at 12h. Representative hematoxylin/eosin-stained sections were examined by light
microscopy (original magniﬁcation: 200x). (a) The CON group, (b) The TC group, (c) The ZP group, and (d) The Z group.
(a) (b)
(c) (d)
Figure 3: Morphologic changes in hepatic injury at 12h. Representative hematoxylin/eosin-stained sections were examined by light
microscopy (original magniﬁcation: 200x). (a) The CON group, (b) The TC group, (c) The ZP group, and (d) The Z group.4 Mediators of Inﬂammation
Table 1: Experimental design of the preliminary research.
Group n Time
−0.5h 0h 12h
Sham-operated group 8 Vehicle (10% DMSO) Saline Sacriﬁce
Acute necrotizing pancreatitis group 8 Vehicle (10% DMSO) Taurocholate Sacriﬁce
Zerumbone pretreated group 5mg/kg 8 Zerumbone 5mg/kg Taurocholate Sacriﬁce
Zerumbone pretreated group 10mg/kg 8 Zerumbone 10mg/kg Taurocholate Sacriﬁce
Zerumbone pretreated group 20mg/kg 8 Zerumbone 20mg/kg Taurocholate Sacriﬁce
Zerumbone pretreated group 40mg/kg 8 Zerumbone 40mg/kg Taurocholate Sacriﬁce
In acute necrotizing pancreatitis group, rats received the vehicle (10% DMSO, 2mL/kg) administered via femoral vein half an hour prior to retrograde
infusion of a freshly prepared 5% sodium taurocholate solution (1mg/kg). In sham-operated group, rats received the vehicle administered via femoralv e i n
andafterhalfanhour,theratswereretrogradeinfusedisotonicsalinesolution(1mL/kg).Inzerumbonepretreatedgroup,ratsreceived5,10,20,and40mg/kg
zerumbone dissolved in vehicle (10% DMSO v/v) administered via femoral vein half an hour prior to infusion 5% sodium taurocholate solution (1mg/kg).
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Figure 4: Pancreatic histopathological scores in all groups. The
pancreatic tissue was with hematoxylin-eosin staining. The sections
were evaluated by two independent pathologists who were blinded
to this research. Time course changes of the pancreatic histological
assessment were scored based on edema, inﬂammation, hemor-
rhage, and necrosis according to the scale described by Schmidt et
al. [19]. aP < 0.05 versus CON group. bP < 0.05 versus TC group.
pretreated group rats. After half an hour of injecting, acute
necrotizing pancreatitis was induced by retrograde infusion
5% sodium taurocholate solution. In sham-operated group,
infusion isotonic saline solution instead of taurocholate. All
rats were sacriﬁced at 12h after induction of pancreatitis
because intrapancreatic damage reached a peak [20]. The
eﬀect of zerumbone was evaluated by the levels of serum
amylase (AMY), secretory phospholipase A2 (sPLA2), and
alanine aminotransferase (ALT), which had been described
before [18].
In the formal study, 10mg/kg zerumbone was adopted
as the optimal dose. 160 male Wistar rats were randomly
divided into four groups: (1) taurocholate + vehicle group
(TC group, n = 64); (2) saline + vehicle as the control
group (CON group, n = 64); (3) taurocholate + zerumbone
group (ZP group, n = 16); (4) saline + zerumbone group (Z
group, n = 16). In the TC group, rats received vehicle (10%
DMSO, 2mL/kg) via femoral vein, half an hour prior to 5%
sodium taurocholate infusion. In the CON group, rats only
received the vehicle. In the ZP group, rats received 10mg/kg
zerumbone dissolved in the vehicle (10% DMSO v/v). In the
Z group, rats received the zerumbone and saline (Table 2).
In the ZP and Z groups, rats were only at the time point of
12h (n = 16). Furthermore, in the TC and CON groups, rats
were subdivided into subgroups of 1, 3, 6, and 12h (n = 16)
(Table 2).
For each group of the two studies, rats were sacriﬁced
by taking blood via heart puncture. Blood samples were
collected for centrifuging, and serum was stored at −20◦C.
After sacriﬁce, the head of the pancreatic tissue and the right
lobe of hepatic tissue were harvested and ﬁxed in 4% PBS-
buﬀered formaldehyde for histopathology observation. The
remaining part of the pancreatic and hepatic tissues were
immediately snap frozen in liquid nitrogen and stored at
−80◦C for assay.
2.4. Enzyme Assay. Plasma amylase (AMY), alanine amino-
transferase (ALT), and aspartate transaminase (AST) were
measuredbyanautomaticbiochemistryanalyzerwithstand-
ard techniques (Olympus Optical Ltd., Japan). Serum sPLA2
activity was measured by sPLA2 Assay Kit according to the
manufacturer’s instructions (Ann Arbor, MI).
2.5. Histopathological Examination. Pancreatic and hepatic
tissues were ﬁxed, subjected to conventional processing and
sectioning, followed by hematoxylin-eosin (H&E) staining.
The sections were evaluated by two pathologists who were
blinded to this study. Pancreatic histological assessment was
determined by edema, inﬂammation, hemorrhage, and ne-
crosis according to the scale described by Schmidt et al. [19].Mediators of Inﬂammation 5
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Figure 5: Cellular localization of NF-κB p65 protein in pancreas in diﬀerent groups (original magniﬁcation: 400x). (a) In the CON group,
weak immunoreactivity mainly in the cytoplasm. (b) In the TC group, intense immunoreactivity in the nucleus. (c) In the ZP group, low
immunoreactivity in the nucleus. (d) Negative control.
Table 2: Experimental design of the formal study.
Group Time
−0.5h 0h 1h 3h 6h 12h
CON Vehicle (10% DMSO) Saline Sacriﬁce (n = 16) Sacriﬁce (n = 16) Sacriﬁce (n = 16) Sacriﬁce (n = 16)
TC Vehicle (10% DMSO) Taurocholate Sacriﬁce (n = 16) Sacriﬁce (n = 16) Sacriﬁce (n = 16) Sacriﬁce (n = 16)
ZP Zerumbone 10mg/kg Taurocholate Sacriﬁce (n = 16)
Z Zerumbone 10mg/kg Saline Sacriﬁce (n = 16)
In the TC group, rats received the vehicle (10% DMSO, 2mL/kg) administered via femoral vein half an hour prior to retrograde infusion of a freshly prepared
5% sodium taurocholate solution (1mg/kg). In the CON group, rats received the vehicle administered via femoral vein. After half an hour, the rats were
retrograde infused isotonic saline solution (1mL/kg). In the ZP group, rats received 10mg/kg zerumbone dissolved in vehicle (10% DMSO v/v) administered
via femoral vein half an hour prior to infusion 5% sodium taurocholate solution (1mg/kg). In the Z group, rats received the same as ZP group except infusion
isotonic saline solution instead of taurocholate.
The severity of hepatic injury was determined by a point-
counting method description by Camargo et al. [21].
2.6. Immunohistochemisty Assay. Pancreatic-tissue sections
(4μm) were obtained from paraﬃn-embedded tissues.
Under deparaﬃnization, 0.3% (v/v) hydrogen peroxide was
used to inactivate endogenous peroxidase activity. The
sections underwent a blocking step with 5% normal goat
serumdilutedinPBS.Endogenousbiotinandavidinbinding
sites were blocked by avidin and biotin, respectively. Sections
were incubated with rabbit polyclonal anti-rat NF-κBp 6 5
antibody (1:200, Sigma, St. Louis, MO) in a moisture cham-
ber. Sections were then counterstained with hematoxylin.
Negative control studies were performed in which PBS was
used instead of primary antibody.
2.7. Western Blot. Proteins (including cytoplasmic and nu-
clearproteins)wereextractedbytheNuclear-CytosolExtrac-
tion Kit (Applygen Technologies Inc., Beijing, China), fol-
lowed by manufacturer’s instructions. Proteins were evalu-
atedbytheBradfordmethodwithbovineserumalbuminasa
standard. 40mg protein samples were electrophoresed in 8%
sodium dodecylsulphate polyacrylamide (SDS-PAGE) gels
and transferred to nitrocellulose membranes. Membranes
were blocked with blocking buﬀer (TBS containing 5% non-
fat dry milk, 0.1% Tween-20) for 2h at room temperature.6 Mediators of Inﬂammation
(a) (b)
(c) (d)
Figure 6: Cellular localization of NF-κB p65 protein in hepatic tissue in diﬀerent groups (original magniﬁcation: 400x). (a) In the CON
group, weak immunoreactivity mainly in the cytoplasm. (b) In the TC group, intense immunoreactivity in the nucleus. (c) In the ZP group,
low immunoreactivity in the nucleus. (d) Negative control.
The cytoplasmic proteins were incubated with primary
antibodies of rabbit polyclonal anti-rat I-κBα antibody
(1:1000, Santa Cruz, CA), actin antibody (1:2000, Santa
Cruz, CA). Meanwhile, the nuclear proteins were incubated
withrabbitpolyclonal anti-rat NF-κBp65antibody (1:2000,
Sigma, St. Louis, MO) and actin antibody (1:2000, Santa
Cruz,CA)overnightat4◦C.Themembranewaswashedwith
TBST (TBS containing 0.05% Tween-20) and then incubated
withhorseradishperoxidase-conjugatedgoatanti-rabbitsec-
ondary antibodies (1:5000, Pierce Biotechnology, Rockford,
IL) for 1h at room temperature. After repeated washings
with TBST,the antibody-antigen complexes were detected by
ECL reagent (Immobilon Western HRP Substrate, Millipore
Corporation, Bedford, MA).
2.8. Reverse Transcriptase Polymerase Chain Reaction (RT-
PCR). Total RNA was extracted from one hundred milli-
gram frozen pancreatic and hepatic tissues. RNA was rever-
se-transcribed to complementary DNA according to the ma-
nufacturer’s instructions of Revert Aid First Strand cDNA
Synthesis Kit (Fermentas, Hanover, MD). Polymerase
chain reaction was performed with the primers for in-
tercellular adhesion molecule-1 (ICAM-1) (F: CGGTAG-
ACACAAGCAAGAGA; R: GCAGGGATTGACCATAATTT;
517bp; NM-012967); interleukin-1β (IL-1β) (F: CCAGGAT-
GAGGACCCAAGCA; R: TCCCGACCATTGCTGTTTCC;
519bp; NM-031512); glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) (F: TCATGAAGTGTGACGTGGACATC;
R: CAGGAGGAGCAATGATCTTGATCT; 309bp; NM-
017008). PCR was performed by using a Gene Cycler (Bio-
Rad, Hercules, CA). Ampliﬁcation steps were ICAM-1
(initial denaturation 94◦C 5min, then denaturation 94◦C
30sec, annealing 56◦C3 0s e c ,e x t e n s i o n7 2 ◦C1m i nf o r3 5
cycles, ﬁnal extension 72◦C 7min); IL-1β (initial denatura-
tion 94◦C 5min, then denaturation 95◦C 30sec, annealing
63◦C4 5 s e c ,e x t e n s i o n7 2 ◦C 35sec for 35 cycles, ﬁnal ex-
tension 72◦C 7min); GAPDH (initial denaturation 94◦C
5min, then denaturation 94◦C 30sec, annealing 55◦C3 0s e c ,
extension 72◦C 80sec for 35 cycles, ﬁnal extension 72◦C
7min). PCR products were electrophoresed in 2% agarose
gel containing ethidium bromide (0.5mg/mL). Gels were
under UV light and then photographed. Band intensity was
determined by optical density with PCR product/GAPDH
ratios.
2.9. Statistical Analysis. All data were expressed as means ±
standard deviation values. Data were compared between all
groups by one-way analysis of variance (ANOVA) except
hepatic histopathological examination, which was analyzed
by Kruskall-Wallis nonparametric test, followed by Mann-
Whitney test. Statistical analysis was performed with the
SPSS statistical package (SPSS 13.0 for Windows; SPSS Inc.,
Chicago,IL).AvalueofP<0.05wasregardedasasigniﬁcant
diﬀerence.Mediators of Inﬂammation 7
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Figure 7: Expression of NF-κBp 6 5a n dI - κBα in pancreatic tissue. 1, 6 CON group; 2, TC group 1h; 3, TC group 3h; 4, TC group 6h; 5,
7 TC group 12h; 8, ZP group; 9, Z group. aP < 0.05 versus CON group. bP < 0.05 versus TC group 1h. cP < 0.05 versus TC group 3h.
dP < 0.05 versus TC group 6h. eP < 0.05 versus TC group 12h. fP < 0.05 versus ZP group.
3. Results
3.1. Preliminary Study Results. The results indicated that
neither 5mg/kg nor 40mg/kg zerumbone improve serum
sPLA2 and ALT levels. Compared to 20mg/kg, concentration
of10mg/kghasalreadyshownsigniﬁcantreductionofsPLA2
and ALT levels (P<0.05) (Table 3).
3.2. Analysis of Serum AMY, sPLA2,A L T ,a n dA S T .Com-
pared with the CON group, the TC group had signiﬁcant
increased serum AMY, sPLA2, ALT, and AST levels from 1h
to 12h (P<0.05) except for 1h sPLA2 and ALT. In the ZP
group, pretreatment with zerumbone signiﬁcantly reduced
serum enzyme levels compared with the TC group (P<
0.05). In Z group, all serum enzyme levels were not signiﬁ-
cant compared with the CON group (Figures 1(a)–1(d)).
3.3. Histopathological Assay. Representative pathological
changesinpancreatictissuewereshowninFigures2(a)–2(d).
Injuries were estimated by Schmidt’s description includ-
ing edema, inﬂammation, hemorrhage, and necrosis [19].
The pancreatic microscopy was similar among the CON
subgroups exhibiting no hemorrhage or necrosis. In the TC
group, 5% sodium taurocholate promoted the destruction
of acinar cell. However, pretreatment with zerumbone de-
creased the pancreatic histopathological score clearly in the
ZP group (Figure 4).
The change in hepatic sections was determined by
Camargo’s description [21]. There were four grades: grade
0: minimal or no evidence of injury; grade I: mild injury
consisting in cytoplasmic vacuolation and focal nuclear pyk-
nosis; grade II: moderate to severe injury with extensive
nuclear pyknosis, cytoplasmic hypereosinophilia, and loss
of intercellular borders; grade III: severe necrosis with dis-
integration of hepatic cords, hemorrhage, and neutrophil
inﬁltration. Pathological changes in hepatic tissue were
shown in Figures 3(a)–3(d). In the TC group, 5% sodium
taurocholate had destroyed most of the liver cells and
caused obvious bleeding. However, the hepatic pathological
grade reduced to a much lower level by pretreatment with
zerumbone in the ZP group (Table 4).
3.4. Immunohistochemisty Analysis. In performing the local-
ization of NF-κB expression, immunohistochemical assay
was used. There were no signiﬁcant changes in the immuno-
reactivity of NF-κBintheCONgr oup .NF -κBexpressionwas
expressed mainly in the cytoplasm in pancreatic or hepatic
tissue (Figures 5(a), 6(a)). Following pancreatitis, NF-κB8 Mediators of Inﬂammation
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Figure 8: Expression of NF-κBp 6 5a n dI - κBα in hepatic tissue. 1, 6 CON group; 2, TC group 1h; 3, TC group 3h; 4, TC group 6h; 5, 7 TC
group 12h; 8, ZP group; 9, Z group. aP < 0.05 versus CON group. bP < 0.05 versus TC group 1h. cP < 0.05 versus TC group 3h. dP < 0.05
versus TC group 6h. eP < 0.05 versus TC group 12h. fP < 0.05 versus ZP group.
Table 3: Preliminary study results of diﬀerent doses of zerumbone.
Group n AMY (U/L) sPLA2 (U/L) ALT (U/L)
Sham-operated group 8 1304.8 ±114.7 519.7 ±63.99 5 .7 ±7.9
Acute necrotizing pancreatitis group 8 6774.8 ±739.0a 789.0 ±124.2a 257.6 ±41.7a
Zerumbone pretreated group 5mg/kg 8 5279.5 ± 857.4a,b 775.5 ±160.9a 230.1 ±50.4a
Zerumbone pretreated group 10mg/kg 8 3342.6 ±542.4a,b,c 621.7 ±73.8 157.5 ±31.2a,b
Zerumbone pretreated group 20mg/kg 8 3440.9 ±575.9a,b,c 625.9 ±108.9 181.7 ±30.3a,b
Zerumbone pretreated group 40mg/kg 8 3073.7 ±461.5a,b,c 667.0 ±108.2a 245.8 ±30.5a
Rats from diﬀerent groups were ended at 12h after sodium taurocholate infusion. The serum amylase (AMY), secretory phospholipase A2 (sPLA2), and
alanineaminotransferase (ALT) in serum was measured by an automaticbiochemistryanalyzer with standard techniques(Olympus OpticalLtd.,Japan).Da t a
were expressed as means ± standard error values. aP < 0.05 versus sham-operated group. bP < 0.05 versus acute necrotizing pancreatitis group. cP < 0.05
versus zerumbone pretreated group 5mg/kg.
immunoreactivityhighlyexpresssedinnucleus(Figures5(b),
6(b)). However, a marked decrease in NF-κB staining was
found in the nucleus with the zerumbone pretreatment
(Figures 5(c), 6(c)), but increase in the cytoplasm. Moreover,
negative control showed no immunoreactivity (Figures 5(d),
6(d)).
3.5. NF-κBp 6 5a n dI - κBα Expression. Figures 7(a)-7(b)
showed peak expression of NF-κB p65 protein in pancreas
occurred at 3h, duration to 6h, decreased at 12h in the TC
group, which was higher than in the CON group. In the ZP
group, the NF-κB p65 expression declined to a much lower
level than in the TC group (P<0.05) (Figures 7(c)-7(d)).
Moreover, only TC group showed a signiﬁcant decrease of I-
κBα expression (Figure 7(e)).
Hepatic NF-κB expression increased gradually after in-
duction of pancreatitis in the TC group and the peak expres-
sion occurred at 12h (Figures 8(a)- 8(b)). Figures 8(c)-8(d)Mediators of Inﬂammation 9
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Figure 9: Expression of ICAM-1 and IL-1β mRNA in pancreatic tissue by RT-PCR analysis. 1–4 GAPDH; 5, CON group; 6, TC group 12h;
7, ZP group; 8, Z group. aP < 0.05 versus CON group. bP < 0.05 versus TC group 12h.
Table 4: Hepatic pathological grades with sodium taurocholate-
induced pancreatitis.
Group n Grade Mean rank
01 23
CON group 12 12 0 0 0 10.5
T C g r o u p 1 201 1 1 0 4 0 .7a
Z P g r o u p 1 204 62 3 1 .5ab
Z group 12 8 3 1 0 15.8
Rats from diﬀerent groups were ended at 12h after sodium taurocholate
infusion. The sections were evaluated by two independent pathologists who
were blinded to this research. The change of hepatic sections was detected
by Camargo’s description [21]. Each value is the number of animals with
grading changes. aP < 0.05 versus CON group. bP < 0.05 versus TC group.
showed that the expression of NF-κB p65 protein in the ZP
group was lower than in the TC group. Furthermore, only
TC group showed a signiﬁcant decrease of hepatic I-κBα
expression (Figure 8(e)).
3.6. ICAM-1 and IL-1β mRNA Expression. In this study,
expressions of ICAM-1 and IL-1β in pancreas were found
to be much higher than in the CON group (P<0.05)
(Figures 9(a)–9(d)). However, these mRNA expressions were
much lower in the ZP group than in the TC group (P<
0.05) (Figures 9(a)– 9(d)). The tendencies of these mRNA
expressions in hepatic tissue (Figures 10(a)–10(d)) were the
same as in pancreas.
4. Discussion
Zerumbone, as a component of a wild ginger, was ﬁrst
isolated and structurally elucidated forty years ago [22]. It
has been widely used in experiments by virtue of its anti-
neoplasms and anti-inﬂammatory properties [13, 15]. This
study was to discuss the alleviating eﬀect of zerumbone on
hepatic injury following acute necrotizing pancreatitis.
In the preliminary study, the 12h time point was chosen
after pancreatitis was induced when intrapancreatic damage
had already peaked during pancreatitis [20, 23]. It indicated
that all concentrations of zerumbone injected via femoral
vein had the ability to attenuate serum AMY. However,
only 10 and 20mg/kg zerumbone could decrease serum
sPLA2 and ALT. Therefore, the minimum eﬀective dose
(optimal dose) was 10mg/kg. It had been reported that
doses of 0.1, 1, 10, 20, and 100mg/kg zerumbone were
tested on Wistar rats via intraperitoneal injection following
cholecystokinin octapeptide-induced pancreatitis. The dose
of 20mg/kg zerumbone was the optimal dose [18]. Another
studyusedmaleICRmice,receivingintraperitonealinjection
of zerumbone (5, 10, 50, and 100mg/kg) to estimate the
eﬀect of zerumbone on paw edema, granuloma, and toxicity10 Mediators of Inﬂammation
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Figure 10: Expression of ICAM-1 and IL-1β mRNA in hepatic tissue by RT-PCR analysis. 1–4 GAPDH; 5, CON group; 6, TC group 12h; 7,
ZP group; 8, Z group. aP < 0.05 versus CON group. bP < 0.05 versus TC group 12h.
test. It was demonstrated that all zerumbone doses could
suppress granulomatous tissue formation in cotton pellet-
induced granuloma test [24].
The increased AMY and sPLA2 levels in the TC group
and the elevated histopathological score of pancreas [25]
indicated that pancreas injury deteriorated gradually follow-
ing ANP. Moreover, the increased AMY and sPLA2 levels
advocated the theory of autodigestion of pancreas. [26]. In
the TC group, increased ALT and AST levels and hepatic
histological examination also showed the damage of hepatic
injury from bad to worse [27]. Is there any relationship
between the changes in pancreatic and hepatic tissues?
Previous researches showed that the active RelA/p65 NF-
κB subunit played an essential role in systemic inﬂammatory
response in pancreatitis [28–30]. Cytoplasmic IκB proteins
were primary regulators interacting with NF-κB subunits in
the cytoplasm of normal cells [31–33]. Upon stimulation,
these IκB proteins were rapidly degraded, allowing NF-κB
translocate into nucleus and activate the transcription of
related genes: ICAM-1 and IL-1β [34–36]. Other studies
showed that downregulation of NF-κB not only inhibited
ICAM-1andIL-1βexpression,butalsoattenuatedpancreatic
and hepatic injury in pancreatitis [35–37].
The result of immunohistochemisty assay indicated that
NF-κB has been shown to translocate from the cytoplasm
into the nucleus upon activation in pancreatic or hepatic
tissues during pancreatitis. The western blot results showed
that the I-κBα protein expression was much lower during
pancreatitis because of rapidly degradation. Pancreatic NF-
κB expression elevated from 1h, peaked at 3h and continued
to 6h following ANP. It is accordance with published data
[38]. The peaking expression of NF-κBi nh e p a t i ct i s s u e
was lagged behind up to 12h following ANP. These results
supported that the early phase of NF-κB activation started
from pancreas by translocating into the nucleus. Up to
12h in ANP, the NF-κB expression in hepatic tissue was
strong due to the inﬂammatory cascade. The multiple organ
dysfunction syndromes may occur relying on the NF-κB
inﬂammatorycascade,iflongerormoreorganswereapplied.
However, the peaking expression of NF-κBi nh e p a t i ct i s s u e
lagged behind in pancreas, thus the period from 3h to 12h
following ANP was deﬁned as “window period,” which was
the potential period for hepatic protection.
It was reported that zerumbone exerted a beneﬁcial
eﬀect on inﬂammation but failed to improve histology [18].
Furthermore, published data indicated that administration
of zerumbone could decrease NF-κB p65 expression [14, 39–
41]. Triptolide as well as zerumbone, was a crude plant
extract and could attenuate hepatic injury and inhibit NF-
κBa c t i v a t i o n[ 42]. Western blot and immunohistochemisty
assay in this study showed that zerumbone inhibited NF-
κB activation and decreased ICAM-1 and IL-1β mRNA
expression. The serum assay and the changes in histopatho-
logicalexaminationindicatedthatzerumboneattenuatedthe
severity of acute necrotizing pancreatitis and pancreatitis-
induced hepatic injury.Mediators of Inﬂammation 11
In summary, this work suggests that zerumbone atten-
uates the severity of acute necrotizing pancreatitis and
pancreatitis-induced hepatic injury, through inhibiting NF-
κB activation and downregulation of intercellular adhe-
sion molecule-1 and Interleukin-1β. However, its complete
molecular mechanism still remains unclear. These works
can serve as a basis for further studies on the therapeutic
potential of zerumbone in acute necrotizing pancreatitis.
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